Buy or sell Emulate stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Emulate Stock
Organs-on-Chips Company
About Emulate Stock
Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.
Investors
ALS Investment Fund
Alumni Ventures Group
Getaround, Better.com, Accolade, Deserve, Upstart, Trifacta, CommonBond, Emulate, Veem, Freshly
ATEL Ventures
Cedars Sinai Medical Center
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Palantir Technologies, Stripe, Wish, Compass, Eat Just, Inc., Flexport
Glass Wall Syndicate
LabCorp
NanoDimension
National Institutes of Health
Starlight Ventures
Funding History
| July 2014 | $12.0M |
|---|---|
| March 2016 | $45.0M |
| June 2018 | $36.0M |
| August 2019 | $50.0M |
Management
Chief Executive Officer
Jim Corbett
Chief Technology Officer
Daniel Levner
Press
PR Newswire - Jan, 11 2021
PR Newswire - Jan, 8 2021
Bio Space - Dec, 21 2020
PR Newswire - Dec, 8 2020
Technology Networks - Nov, 24 2020
xconomy - Mar, 23 2020
news-medical - Mar, 20 2020
Business Wire - Mar, 19 2020
Bandera County Courier - Mar, 9 2020
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Emulate or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
